CVS Group (LON:CVSG) Announces Share Repurchase Plan

CVS Group (LON:CVSG) announced that its Board of Directors has approved a share buyback plan on Tuesday, May 26th, RTT News reports. The company plans to buyback 0 outstanding shares. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

Analyst Ratings Changes

CVSG has been the topic of a number of research analyst reports. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research report on Tuesday. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 1,900 price objective on shares of CVS Group in a research report on Thursday, March 5th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Group currently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,724.

CVS Group Stock Up 5.8%

LON:CVSG traded up GBX 70 on Tuesday, hitting GBX 1,269. The stock had a trading volume of 629,769 shares, compared to its average volume of 986,411. The company has a debt-to-equity ratio of 121.52, a quick ratio of 0.90 and a current ratio of 1.07. The stock has a market cap of £890.29 million, a P/E ratio of 18.42, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. CVS Group has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648. The firm’s fifty day simple moving average is GBX 1,173.65 and its two-hundred day simple moving average is GBX 1,244.30.

CVS Group (LON:CVSG) last posted its quarterly earnings data on Thursday, February 26th. The company reported GBX 40.20 EPS for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. Analysts predict that CVS Group will post 93.9393939 earnings per share for the current year.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.